Clinical Trials
14
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
- Conditions
- Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
- Interventions
- Drug: standard of care
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Keryx Biopharmaceuticals
- Target Recruit Count
- 36
- Registration Number
- NCT04649411
Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease
- Conditions
- Hyperphosphatemia Related to Chronic Kidney Disease
- Interventions
- First Posted Date
- 2020-08-24
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Keryx Biopharmaceuticals
- Target Recruit Count
- 45
- Registration Number
- NCT04523727
- Locations
- 🇺🇸
Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States
🇺🇸University of Alabama at Birmingham (UAB) - Children's of Alabama, Birmingham, Alabama, United States
🇺🇸Phoenix Childrens Hospital, Phoenix, Arizona, United States
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
- First Posted Date
- 2017-08-01
- Last Posted Date
- 2021-03-12
- Lead Sponsor
- Keryx Biopharmaceuticals
- Target Recruit Count
- 206
- Registration Number
- NCT03236246
- Locations
- 🇺🇸
Arizona Kidney Disease and Hypertension center: AKDHC Medical Research Services, LLC, Phoenix, Arizona, United States
🇺🇸California Institute of Renal Research, Poway, California, United States
🇺🇸Denver Nephrologists, P.C., Denver, Colorado, United States
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
- Conditions
- Anemia of Chronic Kidney Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-10-20
- Last Posted Date
- 2018-03-22
- Lead Sponsor
- Keryx Biopharmaceuticals
- Target Recruit Count
- 234
- Registration Number
- NCT02268994
- Locations
- 🇺🇸
AKDHC Medical Research Services, LLC, Phoenix, Arizona, United States
🇺🇸Southwest Kidney Institute, Tempe, Arizona, United States
🇺🇸California Renal Research, Glendale, California, United States
A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia
- First Posted Date
- 2014-05-01
- Last Posted Date
- 2018-08-24
- Lead Sponsor
- Keryx Biopharmaceuticals
- Target Recruit Count
- 32
- Registration Number
- NCT02128074
- Locations
- 🇮🇱
Barzilai Medical Center, Ashkelon, Israel
🇮🇱Western Galilee Hospital, Nahariya, Israel
🇮🇱Nazareth Hospital- EMMS, Nazareth, Israel
- Prev
- 1
- 2
- 3
- Next